US 7094404
Method for treating malignancy and autoimmune disorders in humans using tac antibodies
granted A61KA61K2039/505A61K51/1033
Quick answer
US patent 7094404 (Method for treating malignancy and autoimmune disorders in humans using tac antibodies) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K2039/505, A61K51/1033